University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a potential way to target a subtype of acute
Continue reading »
Yale approach bases decision-making on older adults’ own health priorities
In a pilot project, researchers at Yale, New York University School of Medicine and Baylor College of Medicine have shown
Continue reading »Why daytime naps are the worst approach for jet lag
There is no escaping jet lag: Why daytime naps are the worst approach to adjusting There is no escaping jet
Continue reading »How indigenous and faith healers approach mental health in Ghana
The use of non-biomedical methods to treat mental disorders in developing countries, like Ghana, has long been acknowledged. The World
Continue reading »Specialized approach to open heart surgery saves lives
Patients who undergo coronary artery bypass grafting (CABG)—the most common heart surgery performed—may live longer and experience fewer complications when
Continue reading »Researchers find a promising new approach for treating liver cirrhosis
Increased pressure in the veins leading to the liver, known as portal hypertension (PH), accounts for the majority of medical
Continue reading »New clinical trial takes personalized approach for rare type of ALS in Appalachia
ALS, or amyotrophic lateral sclerosis, is a neurodegenerative disease of some fame in the United States. Many Americans know the
Continue reading »New approach to immunotherapy leads to complete response in breast cancer patient
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression
Continue reading »Looking beyond mutations, researchers take a new approach to an old oncogene
KRAS is one of the most commonly mutated and widely studied genes in cancer; a quick PubMed search for KRAS
Continue reading »New approach to cancer research aims to accelerate studies and reduce cost
A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical
Continue reading »